Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Burger

Showing results (181-190 of 337) with videos related to

Pageof 34
Sort By:
Antiviral Therapy|October 11, 2017
Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescentsWatsamon Jantarabenjakul, Suvaporn Anugulruengkitt, Naruporn Kasipong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2008
Therapeutic drug monitoring of nevirapine in resource-limited settingsRafaëlla F A L'homme, Eva P Muro, Jacqueline A H Droste, et al.
Therapeutic Drug Monitoring|January 29, 2015
Determination of the HCV Protease Inhibitor Telaprevir in Plasma and Dried Blood Spot by Liquid Chromatography-Tandem Mass SpectrometryCorrien P W G M Verweij-van Wissen, Marga J A de Graaff-Teulen, Clara T M M de Kanter, et al.
Clinical Pharmacokinetics|August 10, 2022
Correction to: An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill PatientsEveline Wallenburg, Rob Ter Heine, Jeroen A Schouten, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2015
Altered Micafungin Pharmacokinetics in Intensive Care Unit PatientsVincent J Lempers, Jeroen A Schouten, Nicole G Hunfeld, et al.
Antiviral Therapy|August 20, 2003
Pharmacokinetics of nelfinavir in children: influencing factors and dose implicationsAlina S Bergshoeff, Pieter L A Fraaij, Annemarie M C van Rossum, et al.
Antiviral Therapy|August 3, 2007
Plasma concentrations of the HIV-protease inhibitor lopinavir are suboptimal in children aged 2 years and belowGwenda Verweel, David M Burger, Nancy L Sheehan, et al.
Antiviral Therapy|December 24, 2019
Pharmacokinetics of oral tenofovir disoproxil fumarate in pregnancy and lactation: a systematic reviewMarieke Bierhoff, Elise J Smolders, Joel Tarning, et al.
AIDS (London, England)|March 5, 2008
Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tabletsRafaëlla F A L'homme, Desiré Kabamba, Fiona M Ewings, et al.
Therapeutic Drug Monitoring|February 9, 2018
Development and Validation of a Bioanalytical Method to Quantitate Enzalutamide and its Active Metabolite N-Desmethylenzalutamide in Human Plasma: Application to Clinical Management of Patients With Metastatic Castration-Resistant Prostate CancerGuillemette E Benoist, Eric van der Meulen, Inge M van Oort, et al.
Pageof 34

Showing results (181-190 of 337) with videos related to

Sort By:
Pageof 34
Antiviral Therapy|October 11, 2017
Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescentsWatsamon Jantarabenjakul, Suvaporn Anugulruengkitt, Naruporn Kasipong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2008
Therapeutic drug monitoring of nevirapine in resource-limited settingsRafaëlla F A L'homme, Eva P Muro, Jacqueline A H Droste, et al.
Therapeutic Drug Monitoring|January 29, 2015
Determination of the HCV Protease Inhibitor Telaprevir in Plasma and Dried Blood Spot by Liquid Chromatography-Tandem Mass SpectrometryCorrien P W G M Verweij-van Wissen, Marga J A de Graaff-Teulen, Clara T M M de Kanter, et al.
Clinical Pharmacokinetics|August 10, 2022
Correction to: An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill PatientsEveline Wallenburg, Rob Ter Heine, Jeroen A Schouten, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2015
Altered Micafungin Pharmacokinetics in Intensive Care Unit PatientsVincent J Lempers, Jeroen A Schouten, Nicole G Hunfeld, et al.
Antiviral Therapy|August 20, 2003
Pharmacokinetics of nelfinavir in children: influencing factors and dose implicationsAlina S Bergshoeff, Pieter L A Fraaij, Annemarie M C van Rossum, et al.
Antiviral Therapy|August 3, 2007
Plasma concentrations of the HIV-protease inhibitor lopinavir are suboptimal in children aged 2 years and belowGwenda Verweel, David M Burger, Nancy L Sheehan, et al.
Antiviral Therapy|December 24, 2019
Pharmacokinetics of oral tenofovir disoproxil fumarate in pregnancy and lactation: a systematic reviewMarieke Bierhoff, Elise J Smolders, Joel Tarning, et al.
AIDS (London, England)|March 5, 2008
Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tabletsRafaëlla F A L'homme, Desiré Kabamba, Fiona M Ewings, et al.
Therapeutic Drug Monitoring|February 9, 2018
Development and Validation of a Bioanalytical Method to Quantitate Enzalutamide and its Active Metabolite N-Desmethylenzalutamide in Human Plasma: Application to Clinical Management of Patients With Metastatic Castration-Resistant Prostate CancerGuillemette E Benoist, Eric van der Meulen, Inge M van Oort, et al.
Pageof 34